Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- JAWLINEIndependent statistical analysis of Sequential Treatment With BELKYRA® Then Juvéderm® VOLUMA™ With Lidocaine for Overall Improvement in Jawline Contour: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JENIndependent statistical analysis of Probiotics and Health-related Quality of Life in Individuals With Seasonal Allergies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study: Complete Statistical AnalysisIndependent statistical analysis of JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02732691).
- JET-ISRIndependent statistical analysis of JetStream Atherectomy for the Treatment of In-stent Restenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02730234).
- JETiIndependent statistical analysis of JETi Lower Extremity Arterial Thrombosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04370691).
- Jewel Electrophysiology (EP) Lab Study: Complete Statistical AnalysisIndependent statistical analysis of Jewel Electrophysiology (EP) Lab Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05490459).
- JintronixIndependent statistical analysis of A New Adaptive Physical Activity Technology in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02467491).
- JiVitA-3Independent statistical analysis of Antenatal Micronutrient Supplementation and Infant Survival: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00860470).
- JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- JOTIndependent statistical analysis of Journey of Transformation Curriculum for Native American Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05274217).
- JOTROL PK, Safety, and Food Effect Assessment: Complete Statistical AnalysisIndependent statistical analysis of JOTROL PK, Safety, and Food Effect Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04668274).
- Journeys to Wellness: A Transplant Candidate Study: Complete Statistical AnalysisIndependent statistical analysis of Journeys to Wellness: A Transplant Candidate Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01254214).
- Joyful Parenting Pilot Project RCT Study: Complete Statistical AnalysisIndependent statistical analysis of Joyful Parenting Pilot Project RCT Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03282071).
- JPN ATO OLEIndependent statistical analysis of A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- JPSIndependent statistical analysis of Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Jugular Venous Flow Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Jugular Venous Flow Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002494).
- Jump StartIndependent statistical analysis of Jump Start Shared Medical Appointments for Diabetes With Weight Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01973972).
- Junctional AV Ablation in CRT-D: JAVA-CRT: Complete Statistical AnalysisIndependent statistical analysis of Junctional AV Ablation in CRT-D: JAVA-CRT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02946853).
- JUNGLEIndependent statistical analysis of Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- JUNIPERIndependent statistical analysis of Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- JUNIPERIndependent statistical analysis of Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144: primary endpoint results, effect estimate with confidence interval, sample-size…
- Juno Perth Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Juno Perth Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02317042).
- Just Kwit: Mobile Intervention for Tobacco Cessation: Complete Statistical AnalysisIndependent statistical analysis of Just Kwit: Mobile Intervention for Tobacco Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538678).
- JUVE_BTXIndependent statistical analysis of Study of BOTOX and JUVEDERM for Treatment of Moderate to Severe Facial Wrinkles and Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- K-PASSIndependent statistical analysis of Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- KAIZENIndependent statistical analysis of Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05529472).
- Kaletra and Viread in Antiretroviral Naïve Patients: Complete Statistical AnalysisIndependent statistical analysis of Kaletra and Viread in Antiretroviral Naïve Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00679926).
- KALMARIndependent statistical analysis of Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01068873).
- KAMELEONIndependent statistical analysis of A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors: primary endpoint results, effect estimate with confidence…
- Kangaroo Mother Care to Prevent Hypothermia in Term Infants: Complete Statistical AnalysisIndependent statistical analysis of Kangaroo Mother Care to Prevent Hypothermia in Term Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02189759).
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: Complete Statistical AnalysisIndependent statistical analysis of Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KAPTIndependent statistical analysis of Ketamine for Acute Pain Management After Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04129086).
- KAREIndependent statistical analysis of Ketamine for Reduction of Alcoholic Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02649231).
- KARMA-depIndependent statistical analysis of Ketamine as an Adjunctive Therapy for Major Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03256162).
- KASTPainIndependent statistical analysis of Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01620983).
- KATE2Independent statistical analysis of A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced…
- KavaPKIndependent statistical analysis of Biomarker Changes and Anxiolytic Effects-Phase 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565145).
- KAVIAR Study – Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures: Complete Statistical AnalysisIndependent statistical analysis of KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03919799).
- KEEP-PIndependent statistical analysis of Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers (KEEP-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03106636).
- KEEPS MDBHASIndependent statistical analysis of KEEPS Mammographic Density And Breast Health Ancillary Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02524561).
- KEEPsAKE 1Independent statistical analysis of A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease…
- KEIFER SSTIndependent statistical analysis of Self Selection Trial of Naproxen Sodium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01383486).
- KEM-VOCIndependent statistical analysis of Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02434939).
- KET-ROIndependent statistical analysis of KET-RO Plus RO DBT for Treatment Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06138691).
- Ket-RSIIndependent statistical analysis of Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KETA-2011Independent statistical analysis of Oral Ketamine for Control of Chronic Pain in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01369680).
- KETAFAPIndependent statistical analysis of Ketamine For Acute Treatment of Pain in Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02306759).
- KETAMINEIndependent statistical analysis of Administration of Ketamine to Prevent the Post-operative Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00210210).